Cargando…

Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome

BACKGROUND: High-potency statin therapy is recommended in the secondary prevention of cardiovascular disease but discontinuation, dose reduction, statin switching, and/or nonadherence occur in practice. OBJECTIVES: To determine the prevalence and predictors of deviation from high-potency statin use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Richard M., Yin, Peng, Hanson, Anita, FitzGerald, Richard, Morris, Andrew P., Stables, Rod H., Jorgensen, Andrea L., Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399750/ https://www.ncbi.nlm.nih.gov/pubmed/28391887 http://dx.doi.org/10.1016/j.jacl.2016.12.007

Ejemplares similares

Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention
por: Turner, Richard M., et al.
Publicado: (2020)

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019)

Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis
por: Jorgensen, Andrea L., et al.
Publicado: (2012)

Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)

Optimal inference with suboptimal models: Addiction and active Bayesian inference
por: Schwartenbeck, Philipp, et al.
Publicado: (2015)

Repurposing Statins for Renal Protection: Is It a Class Effect?
por: McWilliam, Stephen J., et al.
Publicado: (2017)

Real-World Data to Identify Hypercholesterolemia Patients on Suboptimal Statin Therapy
por: Kajinami, Kouji, et al.
Publicado: (2019)

Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study
por: Jorgensen, Andrea L., et al.
Publicado: (2019)

Pharmacogenomics for Primary Care: An Overview
por: Rollinson, Victoria, et al.
Publicado: (2020)

Polygenic risk scores: An overview from bench to bedside for personalised medicine
por: Cross, Benjamin, et al.
Publicado: (2022)

Corrigendum to ‘Optimal inference with suboptimal models: Addiction and active Bayesian inference’ [Med. Hypotheses 84 (2015) 109–117]
por: Schwartenbeck, Philipp, et al.
Publicado: (2016)

Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care
por: Curtis, Helen J, et al.
Publicado: (2020)

Statin Eligibility and Outpatient Care Prior to ST‐Segment Elevation Myocardial Infarction
por: Miedema, Michael D., et al.
Publicado: (2017)

Prognosis and New Predictors of Early Left-Ventricular Thrombus Following ST-Elevation Myocardial Infarction
por: Zhang, Qian, et al.
Publicado: (2021)

Parsing interindividual drug variability: an emerging role for systems pharmacology
por: Turner, Richard M, et al.
Publicado: (2015)

Prognosis Between ST-Elevation and Non-ST-elevation Myocardial Infarction in Older Adult Patients
por: Chang, Shih-Sheng, et al.
Publicado: (2022)

Effects of statin response on cardiovascular outcomes in patients with ST-segment elevation myocardial infarction
por: Vatan, Mehmet Bülent, et al.
Publicado: (2022)

Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction
por: Ashoori, Ammar, et al.
Publicado: (2019)

Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction
por: Bouisset, Frédéric, et al.
Publicado: (2021)

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Association of statin use and stress-induced hyperglycemia in patients with acute ST-elevation myocardial infarction
por: Yan, Chen, et al.
Publicado: (2016)

Suboptimal medical care of patients with ST-Elevation Myocardial Infarction and Renal Insufficiency: results from the Korea acute Myocardial Infarction Registry
por: Choi, Joon Seok, et al.
Publicado: (2012)

Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study
por: Turner, R. M., et al.
Publicado: (2020)

Etiologies and Predictors of ST-Segment Elevation Myocardial Infarction
por: Bae, Myung Hwan, et al.
Publicado: (2013)

Statin therapy reduces the likelihood of suboptimal blood pressure control among Ugandan adult diabetic patients
por: Lumu, William, et al.
Publicado: (2017)

Frequency and predictors of suboptimal glycemic control in an African diabetic population
por: Kibirige, Davis, et al.
Publicado: (2017)

aVR ST‐segment changes and prognosis of ST‐segment elevation myocardial infarction
por: Sedighi, Sogol, et al.
Publicado: (2021)

Likelihood and Predictors of ST-Elevation in Patients Hospitalized for Myocardial Infarction
por: Kytö, Ville, et al.
Publicado: (2014)

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study
por: Raymakers, AJN, et al.
Publicado: (2020)

Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink
por: Carr, Daniel F., et al.
Publicado: (2019)

A Review of A Priori Regression Models for Warfarin Maintenance Dose Prediction
por: Francis, Ben, et al.
Publicado: (2014)

Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials
por: Johnson, Danielle, et al.
Publicado: (2019)

ST-elevation versus non-ST-elevation myocardial infarction after combined use of statin with renin–angiotensin system inhibitor: Data from the Korea Acute Myocardial Infarction Registry
por: Kim, Yong Hoon, et al.
Publicado: (2022)

Statin Short-term Inhibition of Insulin Sensitivity and Secretion During Acute Phase of ST-Elevation Myocardial Infarction
por: Sposito, Andrei C., et al.
Publicado: (2019)

Monotherapy versus combination therapy of statin and renin–angiotensin system inhibitor in ST-segment elevation myocardial infarction
por: Kim, Yong Hoon, et al.
Publicado: (2022)

Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
por: Chen, Wenzhong, et al.
Publicado: (2022)

Clinical Predictors and Prognosis of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) without ST-Segment Elevation in Older Adults
por: Gabaldon-Perez, Ana, et al.
Publicado: (2023)

Predictors of mortality in ST-elevation MI patients: A prospective study
por: Zorbozan, Onur, et al.
Publicado: (2018)

Predictors of left ventricular remodeling after ST-elevation myocardial infarction
por: Hendriks, Tom, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_27dh3r06f6bgpod36piqm8is1n